Comparative Causal Analysis of the Effects of Long-Acting Muscarinic Antagonist Versus No Long-Acting Bronchodilator Use on Readmission or Mortality After Hospitalization for Chronic Obstructive Pulmonary Disease

BACKGROUND: Retrospective observational studies may provide real-world evidence about long-acting muscarinic receptor antagonist (LAMA) effectiveness in reducing mortality or COPD-related readmission risk after a COPD hospitalization. Causal inference and competing risk statistical procedures aid in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Drugs Real World Outcomes
Hlavní autoři: Roberts, Melissa H., Mapel, Douglas W., Petersen, Hans
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer International Publishing 2019
Témata:
Original Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7060983/
https://ncbi.nlm.nih.gov/pubmed/31792873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40801-019-00171-w
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky